Ernexa Therapeutics Inc.
ERNAW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000748592
No open-market purchases or sales by Ernexa Therapeutics Inc. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $202.3K in total; no superinvestor holds it.
Other share classesERNA
Superinvestors holding ERNAW, Q2 2026
No superinvestor reported holding ERNAW in Q2 2026.